Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04554147 · ClinicalTrials.gov registry record · NA

Use of an Innovative Mobile Health Intervention to Improve Hypertension Among African-Americans

A NA study of High Blood Pressure, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
16
Enrollment target
3
Study locations

NCT04554147 is a NA study of High Blood Pressure that has completed, run by Mayo Clinic. The registered enrollment target is 16 participants, below the 504-participant average among 23 other High Blood Pressure trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04554147, a NA study of High Blood Pressure, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
3
Study locations

Study Summary

The project objective is to test the feasibility of delivering health education and self-management support to African-American patients with uncontrolled hypertension (HTN) through a culturally-tailored smartphone application (app)-enhanced intervention within federally qualified health centers.

Conditions Studied

Interventions

  • BEHAVIORAL FAITH! App-enhanced Hypertension Intervention

Study Locations (3)

Minnesota

  • North Point Health & Wellness Center - Minneapolis
  • Mayo Clinic - Rochester
  • Open Cities Health Center - Saint Paul

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2021-04-15
Est. Completion 2023-06-30
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04554147

The ClinicalTrials.gov registry entry for NCT04554147 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 504-participant average among 23 other High Blood Pressure trials with a reported enrollment target (97% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with High Blood Pressure appearing as the primary indexed condition, and to 1 intervention - of which FAITH! App-enhanced Hypertension Intervention is the first listed.

NCT04554147 reports 3 study locations spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT04554147 about?

NCT04554147 is a clinical study titled "Use of an Innovative Mobile Health Intervention to Improve Hypertension Among African-Americans". The project objective is to test the feasibility of delivering health education and self-management support to African-American patients with uncontrolled hypertension (HTN) through a culturally-tailored smartphone application (app)-enhanced intervention within federally qualified health centers.

What is the current status of trial NCT04554147?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2021-04-15. Estimated completion is 2023-06-30.

What conditions does trial NCT04554147 study?

This clinical trial studies the following conditions: High Blood Pressure.

What interventions are being tested in trial NCT04554147?

The interventions under investigation include: FAITH! App-enhanced Hypertension Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04554147?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04554147 being conducted?

This trial has 3 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for High Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.